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Introduction
It is known that IL-8 (a proinflammatory cytokine) is released
during and after CPB in adults [1], and in infants and children
[2]. It has recently been shown [2,3] that IL-10 is released
during and after CPB in infants and children. IL-10 serves as
an anti-inflammatory agent and acts via suppressed
macrophage production of proinflammatory mediators [4].
Sex steroids are known to have immunomodulatory functions.
In vitro data [5] has shown that the production of proinflam-
matory cytokines by fibroblasts can be suppressed by pro-
gesterone. The release of T-helper-2-type cytokines, which
are predominantly anti-inflammatory cytokines, appears to be
stimulated by progesterone [6–8]. In a pilot study conducted
CPB = cardiopulmonary bypass; IL = interleukin; MOD = multiple organ dysfunction.
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purpose of the present study was to investigate the plasma levels of progesterone, IL-8 (proinflammatory
cytokine) and IL-10, and to relate them to sex and postoperative morbidity.
Method Eighteen infants and children (eight female) undergoing CPB were prospectively studied.
Plasma levels of progesterone, IL-8 and IL-10 were determined before and 10 min after the start of
CPB, and immediately after CPB; and 6 h, 24 h, 3 days and 7 days postoperatively. Organ dysfunction
was identified on the basis of arbitrarily defined criteria.
Results After CPB, all patients showed significant increases in plasma levels of progesterone, IL-8 and
IL-10. Plasma levels of IL-10 were significantly higher in female patients, except for during the
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in 11 adults (three female) undergoing CPB for coronary–
aortic bypass grafting [9], plasma levels of progesterone
before and after the bypass were measured. Mean proges-
terone levels rose significantly from 0.13 to 0.90 ng/ml.
The purpose of the present study was to investigate the
plasma levels of progesterone, IL-8 and IL-10 during and after
CPB in infants and children, in relation to sex and postopera-
tive morbidity.
Patients and method
Patients
The study was conducted at the University of Ulm. Infants
and children were consecutively enrolled and underwent
CPB if informed consent had been given by the parents. A
total of 18 were included (median age 19 months, range
2 months to 15 years). On the day before the CPB, all
patients had negative plasma levels of C-reactive protein and
were not believed to have infections. Before the elective
operation, the patients were in a haemodynamically stable
condition and none of them had signs of heart failure. Diagno-
sis, type of operation, sex and age at operation of every
patient are summarized in Table 1. None of the patients was
pretreated with β-blockers. Patient 3 (pulmonary atresia with
intact ventricular septum) was on prostaglandin and
furosemide treatment, and patient 8 (ventricular septal
defect) received digoxin. Patients 3 and 15 were cyanotic,
with preoperative arterial oxygen saturations of 80 and 72%,
respectively. Age, body weight and length, and body surface
area were not significantly different between male and female
patients (Table 2). The present study was approved by the
Institutional Review Board of the University of Ulm.
Procedure
Anaesthesia was induced and maintained with fentanyl, mida-
zolam (except in patients 6 and 18, who received clorazepate)
and vecuronium bromide. Further anaesthetics were used in
five male patients (enflurane in patients 9–11 and propofol in
patients 6 and 18) and in three female patients (enflurane in
patients 1, 8 and 13, and propofol in patient 1). A tri-lumen
central venous line was inserted into the internal jugular vein.
For the monitoring of arterial blood pressure, an arterial line
was placed into the radial artery. Volume-controlled ventilation
was applied (SERVO 900C respirator; Siemens, Munich,
Germany). A transurethral catheter was inserted in all patients
in order to monitor fluid balance.
Table 1
Diagnosis, type of operation, sex and age at operation of the 18 infants and children studied
Patient number (sex) Diagnosis Type of operation Age (months)
1 (female) ASD II Closure 55
2 (female) ASD II, AP window Closure, transaortic patch 8
3 (male) PA + IVS, PDA, AS Valvulotomy of PV and AV, closure of PDA, AP shunt 2
4 (female) VSD, PAB Closure, debanding 42
5 (male) VSD Closure 19
6 (male) SAS Resection 182
7 (female) VSD Closure 30
8 (female) VSD Closure 24
9 (male) Fallot, ASD II Correction* 16
10 (male) VSD, SAS, pulmonary hypertension Closure, resection 15
11 (male) VSD, PAB, corrected CoA Closure, debanding 16
12 (female) Fallot, FO Correction 30
13 (female) ASD II, CCAVB Closure 24
14 (male) Fallot, BTA Correction, BTA closure 18
15 (male) Fallot Correction 10
16 (male) Fallot (VACTERL) Correction 20
17 (female) Fallot Correction 17
18 (male) SAS Resection† 185
*Second cardiopulmonary bypass run because of a residual shunt. †Resternotomy because of bleeding. AP = aortopulmonary; AS = aortic valve
stenosis; ASD II, secundum atrioventricular defect; AV = aortic valve; BTA = Blalock–Taussig anastomosis; CCAVB = congenital complete
atrioventricular block; CoA = coarctation of the aorta; Fallot = tetralogy of Fallot; FO = foramen ovale; IVS = intact ventricular septum; PA =
pulmonary atresia; PAB = pulmonary artery banding; PDA = persistent ductus arteriosus; PV = pulmonary valve; SAS = subaortic stenosis;
VACTERL = association of vertebral, anal, cardiac, tracheoesophageal, renal and limb defects; VSD = ventricular septal defect.r
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The CPB was performed using a CAPS-roller pump system
(Stöckert Instruments, Munich, Germany) with continuous flow.
The system was connected to a membrane oxygenator
(Dideco, Sorin Biomedica, Puchheim, Germany; Cobe Optima,
Cobe Laboratories, Planegg-Martinsried, Germany) and an
arterial filter. The priming solution consisted of ringer solution
and sodium bicarbonate, and contained 2 IU/ml heparin-
sodium and 1.5% human albumin. If the haematocrit was
expected to drop to below 25% after the patient was con-
nected to the bypass circuit, then red packed cells were added
(which contained no detectable levels of progesterone).
After the sternotomy had been conducted (patients 1 and 13
had a right-sided thoracotomy for atrial septal defect type II
closure), 30,000 IU/kg aprotinin were administered over a
period of 20 min and the administration was continued with
7500 IU/kg per h throughout the operation. Before cannula-
tion of the patient’s heart, 300 IU heparin-sodium/kg was
given intravenously in order to achieve an activated clotting
time of greater than 400 s. No corticosteroids were given
before or during the operation. After the caval veins, the left
atrium and the aorta had been cannulated, hypothermia was
induced by cooling down the priming solution (median
oesophageal temperature 28.5°C; minimum 28°C and
maximum 33°C). A secundum type atrial septal defect in
patients 1 and 13 was closed under normothermic conditions.
After electrical fibrillation of the heart, 30 ml/kg cold
Bretschneider solution was infused into the cross-clamped
aortic bulbus. The perfusion index was adjusted to 2.5 ml/kg
per m2 with the CPB system. At the end of the procedure
rewarming was started. Catecholamines were used whenever
systemic perfusion was impaired. Heparinization was coun-
tered using 300 IU/kg protamine-hydrochloride. The ventilated
patients were transferred to the cardiac intensive care unit.
The patients were weaned from the respirator as soon as
possible. Crystalloid fluid management consisted of 40 ml/kg
per day during the first postoperative day, increasing by
approximately 10 ml/kg every other day. Fresh frozen plasma
or thrombocytes were given if the patient had postoperative
bleeding (>3 ml/kg per h), or if the prothrombin time was
below 40% of normal or the thrombocyte count was below
50,000/µl, respectively. Furosemide (0.5–1 mg/kg per dose)
was used to facilitate diuresis. Blood pressure was main-
tained within age-specific ranges with catecholamines
(dopamine, dobutamine, adrenaline, noradrenaline).
Laboratory data
Blood samples were taken immediately before the operation;
after induction of anaesthesia and administration of heparin;
10 min after the commencement of CPB; after disconnection
from the circuit and administration of protamine; and 6 h,
24 h, 3 days and 7 days postoperatively. Additional blood
samples were taken when this was clinically indicated.
Blood cell counts, electrolytes, urea nitrogen, creatinine,
protein, creatine kinase, heart-specific creatine kinase, aspar-
tate aminotransferase, bilirubin, prothrombin time, partial
thromboplastin time, fibrinogen and antithrombin III were mea-
sured using standard methods. Plasma levels of progesterone
were measured in EDTA-medium using a RIA-kit (Coat-A-
Count Progesterone; Diagnostic Products Corporation, Los
Angeles, CA, USA). The detection limit was 0.02 ng/ml. The
intra- and inter-assay coefficient of variation was 4.0 and 5.3%
at 1.5 ng/ml, respectively. The test has no detectable cross-
reactivity with aldosterone. IL-8 plasma levels were determined
immediately after the blood was drawn (EDTA-coated tubes)
using a chemiluminescence immunoassay (Immulite; DPC-
Biermann, Bad Nauheim, Germany). The lower detection limit
Available online http://ccforum.com/content/5/6/343
Table 2
Physical characteristics of the patients, and operative and outcome measures
Parameter Male (n = 10) Female (n = 8) P
Age (months) 17 (2–185) 27 (8–55) 0.21
Body weight (kg) 9.6 (4.0–68) 10.4 (5.7–16) 0.72
Body length (cm) 80 (54–169) 81 (65–102) 0.76
Body surface area (m2) 0.45 (0.23–1.78) 0.46 (0.30–0.68) 0.72
Cardiopulmonary bypass time (min) 103 (79–218)* 89 (27–131) 0.08
Cross-clamping (min) 71 (31–129)* 46 (13–93) 0.10
Mechanical ventilation (h) 17 (2–111) 4.8 (2–18) 0.20
Intensive care unit (days) 2 (1–20) 2 (1–5) 0.51
Multiple organ dysfunction (n) 6 0 0.01
Median (minimum, maximum) age, body weight and length, body surface area at operation and duration of cardiopulmonary bypass, aortic cross-
clamping time, duration of mechanical ventilation, and days on the intensive care unit for male and female patients (Mann–Whitney U-test). The
incidence of multiple organ dysfunction is also shown (Fisher’s exact test). *Times for the patient who underwent a second cardiopulmonary bypass
run because of a residual shunt are cumulative.for this assay was 5 pg/ml. The assay was calibrated up to
10,000 pg/ml. Intra- and inter-assay coefficient of variation
was below 5% and below 2% at 95 pg/ml, respectively. All IL-
10 plasma samples (EDTA-coated tubes) were frozen at
–70°C and then measured using an enzyme-linked immunoas-
say (LD Zytokit IL-10 ELISA; LD Labordiagnostica, Heiden,
Germany). The assay had a lower limit of detection of
15 pg/ml. Intra- and inter-assay coefficient of variation was 4.0
and 5.5% at 130 pg/ml, respectively. The IL-10 levels at 6 h
postoperatively could not be measured because immediate
workup of the samples was not possible.
Clinical criteria for multiple organ dysfunction
The different organ systems considered and the criteria used
to define the dysfunction of an organ system are summarized
in Table 3. MOD was diagnosed if two or more organ
systems were affected. The occurrence of organ dysfunction
was monitored for as long as the patient was in the intensive
care unit.
Statistical analysis
The nonparametric Mann–Whitney U-test and the Wilcoxon
test were used to analyze the results. Medians with interquar-
tile ranges were used in the graphs. Correlations were calcu-
lated using Spearman’s method. Differences in outcome
were analyzed using the Fisher’s Exact Test for categorical
variables.  P < 0.05 was considered statistically significant.
Because of the small sample size, no multivariate regression
analysis was performed. This was an explorative study
without confirmatory design, and therefore no correction for
repeated comparisons was performed.
Results
After CPB, all patients showed a significant increase in
plasma levels of progesterone, IL-8 and IL-10 (Wilcoxon test).
Plasma levels of progesterone and IL-8 showed no differ-
ences between male and female patients (Fig. 1; Mann–
Whitney U-test). Plasma levels of IL-10 were significantly
greater in female patients, except for during the immediate
postoperative period (Fig. 1). Progesterone plasma levels
were not correlated to patient age. No correlation between
progesterone and IL-10 plasma levels in female patients was
found at any sample time. After disconnection from the
bypass circuit, plasma levels of IL-8 and IL-10, but not that of
progesterone, were significantly correlated to the duration of
the CPB (r = 0.54 and 0.60, P < 0.05 and P < 0.01 Spear-
man’s method, respectively).
CPB time, aortic cross-clamping time, duration of mechanical
ventilation and days on the intensive care unit for the male and
female patients are summarized in Table 2. There were no sig-
nificant differences between the two groups. According to the
defined criteria for organ dysfunction, six out of 10 male
patients but none of the female patients developed MOD
(P = 0.01). The haematological system was most frequently
affected (83%, n = 15), followed by the cardiac and renal
systems (22% each), and hepatic and neurological systems
(6% each). None of the patients needed ventilatory support for
more than 5 days postoperatively, and all patients survived.
Discussion
Normative data for the prepubertal age show no sex-specific
differences in plasma levels of progesterone [10], and this
was found for the preoperative values in the predominantly
prepubertal patients included in the present study. During
CPB plasma progesterone levels increased in all patients,
with no correlation to patient age or sex. It is unlikely that the
progesterone increase is of gonadal origin. We did not deter-
mine the level of gonadotrophic hormones during and after
bypass. No changes in the secretion rate of luteinizing
hormone were found during and after CPB in adults [11]. An
increase in aldosterone level after open heart surgery has
been described in children [12] and adults [13]. For adult
patients, it has been suggested that activation of the
renin–angiotensin–aldosterone axis may be responsible for
the observed changes in plasma aldosterone [13]. Proges-
terone is a precursor of aldosterone synthesis in the adrenal
cortex. Whether the increase in plasma levels of proges-
terone during and after CPB is caused by an activated
renin–angiotensin–aldosterone axis or whether the increase
is the result of a CPB-related diminished metabolic rate for
progesterone remains unknown.
Critical Care    December 2001 Vol 5 No 6 Trotter et al.
Table 3
Definition of organ dysfunction
Dysfunctional organ system Criteria
Renal Urine output ≤1 ml/kg per h or serum creatinine ≥100 µmol/l
Respiratory Ventilatory support with inspired oxygen fraction ≥0.4 for more than 5 days postoperatively
Hepatic Aspartate aminotransferase ≥500 IU/L or prothrombin time* ≤50%
Cardiac Need for catecholamines >24 h postoperatively†
Haematological Thrombocytes <100,000/µl
Neurological Seizures or coma
*Patient/control value. †Dopamine <5 µg/kg per min excluded.It has been suggested that IL-10 may play a protective role by
downregulating the production of proinflammatory cytokines
after CPB [2]. We identified an increase in IL-10 levels,
peaking after the disconnection from the bypass circuit,
which is in accordance with recently published data [3]. In
vitro data [14,15] showed that, after administration of exoge-
neous progesterone, β2-adrenoreceptors on lymphocytes are
upregulated in females, but not in males. The β2-adreno-
receptor is known to mediate anti-inflammatory effects (e.g.
the release of IL-10 [16]). On the basis of these in vitro data,
it can be speculated that even identical amounts of proges-
terone may result in different anti-inflammatory effects in
females as compared with males. No correlation was found
between plasma levels of progesterone and IL-10 in the
female patients included in the present study. In recent
studies addressing human sepsis [17,18], women had a
Available online http://ccforum.com/content/5/6/343
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Figure 1
Plasma levels of progesterone (upper panel), IL-8 (middle panel) and IL-10 (lower panel; semi-logarithmic Y-scale) at different sample times for
female (n = 8, open bars) and male (n = 10, hatched bars) patients (*P < 0.05, medians with interquartile ranges). The horizontal bar represents
the period of cardiopulmonary bypass (CPB).significantly better prognosis than did men, and this was
related to increased levels of IL-10 in the women. In contrast
to those findings, female sex was identified as a risk factor for
mortality after cardiac surgery with CPB [19].
Evaluation of the clinical course following cardiac surgery
was conducted by defining organ dysfunction. There is some
controversy in the literature that is relevant to the definition of
organ dysfunction in infants and children. If we apply the
MOD criteria defined by Wilkinson et al. [20] to the present
data, the incidence of MOD would have been 50% (n = 9).
Wilkinson et al. found an incidence of MOD of 27% in 831
paediatric intensive care unit patients, but they did not distin-
guish between postoperative cardiac surgery patients and
others. Seghaye et al. [21] used a different definition of MOD
for patients following cardiac surgery. If we apply those crite-
ria to our patients, the incidence of MOD would have been
only 6% (n = 1). We arbitrarily defined the criteria for organ
dysfunction that fitted best the postoperative morbidity of our
patients. All patients included in the present study who devel-
oped MOD were male. This would suggest that sex is the
main factor in determining postoperative morbidity in infants
and children. However, our arbitrary definition of organ dys-
function has limitations. Thrombocytopenia was the most
common finding, the sample size was small, and the patients
had various diagnoses and types of operation.
To our knowledge, this is the first study in which proges-
terone and the changes that occur in its plasma levels during
and after CPB have been followed. After CPB a significant
and marked increase in plasma levels of progesterone was
identified. We were also able to confirm the known CPB-
induced release of IL-8 and IL-10. Female patients had signifi-
cantly higher plasma levels of IL-10 even preoperatively, and
none of them developed MOD. Sex-related differences in
postoperative morbidity cannot be supported by these prelim-
inary data. Limitations include the small and very inhomoge-
neous group of patients with regard to age and diagnosis,
and the arbitrary definition of MOD. Studies of administration
of progesterone-blocking substances in male and female
animals may help to elucidate the role of sex and proges-
terone in the setting of CBP.
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